Research And Development
Health
Manufacturing

Immunomedics

$14.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.25 (1.76%) Today
$0.00 (0.00%) As of 4:06 PM EDT after-hours

Why Robinhood?

You can buy or sell Immunomedics and other stocks, options, ETFs, and crypto commission-free!

About IMMU

Immunomedics, Inc. Common Stock, also called Immunomedics, is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. Read More It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

CEO
Employees
346
Headquarters
Morris Plains, New Jersey
Founded
1982
Market Cap
2.72B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.51M
High Today
$14.56
Low Today
$14.04
Open Price
$14.31
Volume
1.65M
52 Week High
$27.33
52 Week Low
$11.55

Collections

Research And Development
Health
Manufacturing
Cancer Prevention
Pharmaceutical
Biopharmaceutical
Medical
Biotechnology

IMMU Earnings

-$0.68
-$0.46
-$0.24
-$0.02
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected Aug 9, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.